Combining immunological and targeted agents in melanoma

Bookmark and Share
Published: 26 Jun 2014
Views: 2577
Dr Axel Hoos - GlaxoSmithKline, Collegeville, USA

Dr Hoos talks to ecancertv at WIN 2014 about his investigation of immunological and targeted approaches being combined in particular ways to successfully treat metastatic melanoma, with the aim to expand the approach to other cancers.